It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2010.
2010 | Nagpur, Maharashtra, India | ActiveRholence Pharmaceuticals Private Limited, a active private limited company, was established on 12 February 2010 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100MH2010PTC200028. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Pratima Rajendra Dhole (Director), Rajendra Sheshrao Dhole (Director). Past directors included Kiran Ravindra Dhole, Ravindra Sheshrao Dhole. It holds ₹0.89 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 103, New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla, Nagpur, Maharashtra, 440024.
U24100MH2010PTC200028
200028
12 February 2010
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Rholence Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pratima Rajendra Dhole | Director | 12 Feb 2010 | Current |
| Rajendra Sheshrao Dhole | Director | 12 Feb 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Dec 2018 | Past |
| Pramod Abcsdd | Director | 07 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rholence Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 6.3% increase. The company also saw a substantial improvement in profitability, with a 130.54% increase in profit. The company's net worth moved up by a moderate rise of 0.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Rholence Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹892,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jun 2020 | Others | ₹0.09 M | Open |
| 28 Feb 2019 | Others | ₹0.80 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rholence Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rholence Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rholence Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rholence Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Rholence Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge with Others amounted to Rs. 0.09 M with Charge ID 100358637 was registered on 08 Jun 2020. was completed.
The activity A charge with Others amounted to Rs. 0.80 M with Charge ID 100248337 was registered on 28 Feb 2019. was completed.
Pratima Rajendra Dhole was appointed as a Director was appointed as a Director on 12 Feb 2010 & has been associated with this company since 15 years 10 months . was recorded as a recent event.
Rajendra Sheshrao Dhole was appointed as a Director was appointed as a Director on 12 Feb 2010 & has been associated with this company since 15 years 10 months . was recorded as a recent event.
The CIN of Rholence Pharmaceuticals Private Limited is U24100MH2010PTC200028.
Rholence Pharmaceuticals Private Limited is headquartered at 103, New Subhedar Layout Beside Dr. Mahale Clinic Basheshwar Putla, Nagpur, Maharashtra, 440024.
Rholence Pharmaceuticals Private Limited was incorporated on 12 February 2010.
The current directors of Rholence Pharmaceuticals Private Limited are
The primary industry of Rholence Pharmaceuticals Private Limited is Trade.
Rholence Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rholence Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Rholence Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX